Matthew R. Stober is the President and Chief Executive Officer of Istari Oncology. With more than 30 years of leadership experience at large, multinational pharmaceutical organizations, Mr. Stober has led multiple strategic corporate transactions, including major acquisitions and divestitures.
Garrett Nichols, MD, MS, is the Consulting Medical Officer at Istari Oncology. With more than 20 years in the life sciences industry, Dr. Nichols brings vast experience managing the global development efforts of multiple cancer therapeutics stemming from his achievements at large, multinational pharmaceutical organizations to his role at the company.
Jamie Iudica is the Consulting Manufacturing Officer at Istari Oncology. With more than 25 years in the pharmaceutical industry, Mr. Iudica brings a wide range of leadership experience in engineering, manufacturing, and supply-chain operation to his role at the company.
Mr. Higgins is the Corporate and Commercial Development Consultant for Istari Oncology. With 30 years of extensive commercial experience, Mr. Higgins lends a deep understanding of oncology and rare disease to his role, including a proven track record spanning commercial operations, strategic planning, business development, product launches, and sales achievements across the full product life cycle.
Rob Melfi is Chief of Staff and Director, Program Management at Istari Oncology, where he focuses on the development and execution of strategic initiatives across programs and functions. Mr. Melfi brings more than 7 years of experience in strategy development and execution, process analysis and improvement, quantitative and qualitative evaluation of strategic options, and program stakeholder management to his role at the company.